Rising vape pod popularity disrupted declining use of electronic nicotine delivery systems among young adults in Texas, USA from 2014 to 2019.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
01 2022
Historique:
revised: 08 03 2021
received: 10 12 2020
accepted: 09 06 2021
pubmed: 24 6 2021
medline: 2 2 2022
entrez: 23 6 2021
Statut: ppublish

Résumé

To examine the longitudinal trajectory of young Texan (US) adults' electronic nicotine delivery systems (ENDS) use from 2014 to 2019, and to determine if there are changes in the trajectory among younger and older young adults post-2017, when vape pods surged in popularity in the United States. Nine-wave longitudinal study, with 6 months between each of the first eight waves and 1 year between the last two waves. Discontinuous, or piecewise, growth curve models were used to test the hypotheses that (a) the overall current/past 30-day ENDS use trajectory would decline from 2014 to spring 2017 but then increase from fall 2017 to 2019, and (b) the increasing trajectory from 2017 to 2019 would occur only for younger participants, but not older participants. All models included socio-demographic covariates of sex, race/ethnicity, type of college attended at baseline (2- or 4-year) and time-varying age. A total of 5218 students (aged 18-25 years at baseline; 63.7% female) from 24 colleges in the five counties surrounding Austin, Dallas/Fort Worth, Houston and San Antonio, Texas, USA. Participants completed on-line surveys regarding past 30-day ENDS use at all nine waves. Current ENDS use significantly declined from 2014 to spring 2017 [odds ratio (OR) = 0.63, 95% confidence interval (CI) = 0.59-0.68], and then significantly increased from autumn 2017 to 2019 (OR = 1.14, 95% CI = 1.01-1.29). Further examination indicated the increase in current ENDS use from autumn 2017 to 2019 occurred only for younger [-1 standard deviation (SD) below the mean age, 22.6 years old], but not older (+1 SD above the mean age, 26.2 years old), participants. The surge in the popularity of vape pods in the United States in late 2017 may have contributed to increasing use of electronic nicotine delivery systems among younger young adults (below 22.6 years) from late 2017 to 2019.

Identifiants

pubmed: 34159679
doi: 10.1111/add.15616
pmc: PMC8664970
mid: NIHMS1716525
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

216-223

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD042849
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA180906
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA249883
Pays : United States

Informations de copyright

© 2021 Society for the Study of Addiction.

Références

JAMA. 2018 Oct 2;320(13):1379-1380
pubmed: 30285167
Tob Control. 2019 Mar;28(2):146-151
pubmed: 29853561
Addict Behav. 2020 Aug;107:106402
pubmed: 32224428
Am J Public Health. 2019 Mar;109(3):465-471
pubmed: 30676800
Nicotine Tob Res. 2019 Mar 30;21(4):458-468
pubmed: 29452385
MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019
pubmed: 31725711
Tob Regul Sci. 2017 Apr;3(2):168-173
pubmed: 28775996
Tob Control. 2019 Nov;28(6):676-677
pubmed: 30194085
J Adolesc Health. 2020 Jan;66(1):48-55
pubmed: 31481286
Drug Alcohol Depend. 2019 Oct 1;203:1-7
pubmed: 31386973
Tob Control. 2019 Jan;28(1):50-59
pubmed: 29695458
Am J Public Health. 2002 Jun;92(6):908-16
pubmed: 12036776
Tob Control. 2019 Jan;28(1):115-116
pubmed: 29669749
BMJ Open. 2019 Apr 4;9(4):e026306
pubmed: 30948599
JAMA Pediatr. 2020 Mar 1;174(3):277-286
pubmed: 31961395
Tob Control. 2020 Dec;29(e1):e150-e151
pubmed: 32001606
J Appl Physiol (1985). 2020 Apr 1;128(4):1056-1058
pubmed: 31854246
Prev Med. 2020 Mar;132:105954
pubmed: 31917304
J Adolesc Health. 2018 Oct;63(4):413-420
pubmed: 30001826
J Adolesc Health. 2020 Jul;67(1):46-52
pubmed: 32192827
Addict Behav. 2001 Jul-Aug;26(4):517-29
pubmed: 11456075
N Engl J Med. 2017 Jan 26;376(4):342-353
pubmed: 28121512
JAMA. 2019 Nov 12;322(18):1824-1827
pubmed: 31524940
Tob Control. 2020 May;29(Suppl 3):s147-s154
pubmed: 32321848

Auteurs

Alexandra Loukas (A)

Kinesiology and Health Education, University of Texas at Austin, Austin, TX, USA.

C Nathan Marti (CN)

Kinesiology and Health Education, University of Texas at Austin, Austin, TX, USA.

Keryn E Pasch (KE)

Kinesiology and Health Education, University of Texas at Austin, Austin, TX, USA.

Melissa B Harrell (MB)

Epidemiology, Human Genetics, and Environmental Sciences, The University of Texas Health Science Center at Houston School of Public Health, Austin, TX, USA.

Anna V Wilkinson (AV)

Epidemiology, Human Genetics, and Environmental Sciences, The University of Texas Health Science Center at Houston School of Public Health, Austin, TX, USA.

Cheryl L Perry (CL)

Health Promotion and Behavioral Sciences, The University of Texas Health Science Center at Houston School of Public Health, Austin, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH